Literature DB >> 17046272

Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.

Catherine Kielar1, Lucy Maddox, Ellen Bible, Charlie C Pontikis, Shannon L Macauley, Megan A Griffey, Michael Wong, Mark S Sands, Jonathan D Cooper.   

Abstract

Infantile neuronal ceroid lipofuscinosis (INCL) is caused by deficiency of the lysosomal enzyme, palmitoyl protein thioesterase 1 (PPT1). We have investigated the onset and progression of pathological changes in Ppt1 deficient mice (Ppt1-/-) and the development of their seizure phenotype. Surprisingly, cortical atrophy and neuron loss occurred only late in disease progression but were preceded by localized astrocytosis within individual thalamic nuclei and the progressive loss of thalamic neurons that relay different sensory modalities to the cortex. This thalamic neuron loss occurred first within the visual system and only subsequently in auditory and somatosensory relay nuclei or the inhibitory reticular thalamic nucleus. The loss of granule neurons and GABAergic interneurons followed in each corresponding cortical region, before the onset of seizure activity. These findings provide novel evidence for successive neuron loss within the thalamus and cortex in Ppt1-/- mice, revealing the thalamus as an important early focus of INCL pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17046272      PMCID: PMC1866219          DOI: 10.1016/j.nbd.2006.09.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  42 in total

Review 1.  Microglial response to brain injury: a brief synopsis.

Authors:  W J Streit
Journal:  Toxicol Pathol       Date:  2000 Jan-Feb       Impact factor: 1.902

2.  Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice.

Authors:  P Gupta; A A Soyombo; A Atashband; K E Wisniewski; J M Shelton; J A Richardson; R E Hammer; S L Hofmann
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

3.  Ocular phenotype in a mouse gene knockout model for infantile neuronal ceroid lipofuscinosis.

Authors:  Bo Lei; Gregory E Tullis; Mark D Kirk; Keqing Zhang; Martin L Katz
Journal:  J Neurosci Res       Date:  2006-10       Impact factor: 4.164

4.  Centromedian-thalamic and hippocampal electrical stimulation for the control of intractable epileptic seizures.

Authors:  M Velasco; F Velasco; A L Velasco
Journal:  J Clin Neurophysiol       Date:  2001-11       Impact factor: 2.177

Review 5.  Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis.

Authors:  Jonathan D Cooper
Journal:  Curr Opin Neurol       Date:  2003-04       Impact factor: 5.710

6.  Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.

Authors:  Ellen Bible; Praveena Gupta; Sandra L Hofmann; Jonathan D Cooper
Journal:  Neurobiol Dis       Date:  2004-07       Impact factor: 5.996

7.  Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis.

Authors:  Megan Griffey; Ellen Bible; Carole Vogler; Beth Levy; Praveena Gupta; Jonathan Cooper; Mark S Sands
Journal:  Neurobiol Dis       Date:  2004-07       Impact factor: 5.996

8.  Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.

Authors:  Charlie C Pontikis; Claire V Cella; Nisha Parihar; Ming J Lim; Shubhodeep Chakrabarti; Hannah M Mitchison; William C Mobley; Payam Rezaie; David A Pearce; Jonathan D Cooper
Journal:  Brain Res       Date:  2004-10-15       Impact factor: 3.252

9.  The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function.

Authors:  Jui-Yun Lu; Linda A Verkruyse; Sandra L Hofmann
Journal:  Biochim Biophys Acta       Date:  2002-06-13

Review 10.  Microglia as neuroprotective, immunocompetent cells of the CNS.

Authors:  Wolfgang J Streit
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  75 in total

1.  Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; Angelika Saje; Andrew Wong; Serena Ramji; Jonathan D Cooper; David A Pearce
Journal:  Neuropharmacology       Date:  2012-06-06       Impact factor: 5.250

Review 2.  Pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Cinzia Maria Bellettato; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2010-04-29       Impact factor: 4.982

3.  Combination small molecule PPT1 mimetic and CNS-directed gene therapy as a treatment for infantile neuronal ceroid lipofuscinosis.

Authors:  Marie S Roberts; Shannon L Macauley; Andrew M Wong; Denis Yilmas; Sarah Hohm; Jonathan D Cooper; Mark S Sands
Journal:  J Inherit Metab Dis       Date:  2012-02-07       Impact factor: 4.982

4.  Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.

Authors:  Attila D Kovács; Angelika Saje; Andrew Wong; Gábor Szénási; Péter Kiricsi; Eva Szabó; Jonathan D Cooper; David A Pearce
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

5.  Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.

Authors:  Rozzy Finn; Attila D Kovács; David A Pearce
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

6.  Considerations for the treatment of infantile neuronal ceroid lipofuscinosis (infantile Batten disease).

Authors:  Mark S Sands
Journal:  J Child Neurol       Date:  2013-09       Impact factor: 1.987

7.  Neuropeptide changes and neuroactive amino acids in CSF from humans and sheep with neuronal ceroid lipofuscinoses (NCLs, Batten disease).

Authors:  Graham W Kay; Marcel M Verbeek; Julie M Furlong; Michèl A A P Willemsen; David N Palmer
Journal:  Neurochem Int       Date:  2009-08-05       Impact factor: 3.921

8.  A murine model of infantile neuronal ceroid lipofuscinosis-ultrastructural evaluation of storage in the central nervous system and viscera.

Authors:  Nancy Galvin; Carole Vogler; Beth Levy; Attila Kovacs; Megan Griffey; Mark S Sands
Journal:  Pediatr Dev Pathol       Date:  2007-05-23

9.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

10.  Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.

Authors:  Catherine Kielar; Thomas M Wishart; Alice Palmer; Sybille Dihanich; Andrew M Wong; Shannon L Macauley; Chun-Hung Chan; Mark S Sands; David A Pearce; Jonathan D Cooper; Thomas H Gillingwater
Journal:  Hum Mol Genet       Date:  2009-07-29       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.